Hyperbaric oxygen therapy prevents coagulation disorders in an experimental model of multiple organ failure syndrome

Intensive Care Medicine

Volumn 32, Issue 11, 2006, Pages 1881-1888

  Imperatore, Francesco ^a   Cuzzocrea, Salvatore ^b,c   De Lucia, Domenico ^a   Sessa, Marcella ^a   Rinaldi, Barbara ^a   Capuano, Annalisa ^a   Liguori, Giovanni ^a   Filippelli, Amelia ^a   Rossi, Francesco ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Hemocoagulation; Hyperbaric oxygen therapy; Multiple organ failure syndrome; Zymosan

Indexed keywords

FIBRIN; FIBRINOGEN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTERIAL PRESSURE; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; HEMODYNAMIC MONITORING; HYPERBARIC OXYGEN; HYPERCOAGULABILITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; THERAPY EFFECT; TREATMENT OUTCOME;

ANIMALS; BLOOD COAGULATION DISORDERS; HYPERBARIC OXYGENATION; MALE; MULTIPLE ORGAN FAILURE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL ANALYSIS; ZYMOSAN;

EID: 33750209869     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0367-3     Document Type: Article

References (39)

1. Cohen IL (1993) Definition for sepsis and organ failure. The ACCP/SCCM Consensus Conference Committee report. Chest 103:656-666
2. Bone RC (1991) The pathogenesis of sepsis. Ann Inter Med 115:457-469
3. Kidokoro A, Iba T, Fukunaga M, Yagi Y (1996) Alterations in coagulation and fibrinolysis during sepsis. Shock 5:223-228
4. Dixon B (2004) The role of microvascular thrombosis in sepsis. Anaesth Intensive Care 32:619-629
5. Short MA (2004) Linking the sepsis triad of inflammation, coagulation, and suppressed fibrinolysis to infants. Adv Neonatal Care 4:258-273
6. van Hinsbergh VW (2001) The endothelium: vascular control of haemostasis. Eur J Obstet Gynecol Reprod Biol 95:198-201
7. Caille V, Bossi P, Grimaldi D, Vieillard-Baro A (2004) Physiopathology of severe sepsis. Presse Med 33:256-261
8. Cuzzocrea S, Zingarelli B, Sautebin L, Rizzo A, Crisafulli C, Campo GM, Costantino G, Calapai G, Nava F, Di Rosa M, Caputi AP (1997) Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide. Shock 4:268-275
9. Mainous MR, Tso P, Berg RD, Deitch EA (1991) Studies of the route, magnitude and time course of bacterial translocation in a model of systemic inflammation. Arch Surg 126:33-37
10. Cuzzocrea S, Filippelli A, Zingarelli B, Falciani M, Caputi AP, Rossi F (1997) Role of nitric oxide in a non-septic shock model induced by zymosan in the rat. Shock 7:351-357
11. Luongo C, Imperatore F, Cuzzocrea S, Filippelli A, Scafuro MA, Mangoni G, Portolano F, Rossi F (1998) Effects of hyperbaric oxygen exposure on zymosan-induced shock model. Crit Care Med 26:1972-1976
12. Imperatore F, Cuzzocrea S, Luongo C, Liguori G, Scafuro MA, De Angelis A, Rossi F, Caputi AP, Filippelli A (2004) Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome. Intensive Care Med 30:1175-1181
13. Lagaud GJ, Stoclet JC, Andriantsitohaina R (1996) Calcium handling and purinoceptor subtypes involved in ATP-induced contraction in rat small mesenteric arteries. J Physiol 492:689-703
14. Ersoz G, Ocakcioglu B, Bastug M, Ficicilar H, Yavuzer S (1998) Platelet aggregation and release function in hyperbaric oxygenation. Undersea Hyperb Med 25:229-232
15. McCuskey RS, Urbaschek R, Urbaschek B (1996) The microcirculation during endotoxemia. Cardiovasc Res 32:752-763
16. Levi M (2004) Current understanding of disseminated intravascular coagulation. Br J Haematol 124:567-576
17. Levi M, de Jonge E, van der Poll T (2003) Sepsis and disseminated intravascular coagulation. J Thromb 16:43-47
18. Levi M, de Jonge E, van der Poll T (2004) New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med 36:41-49
19. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T (1999) Clinical implications of the "no reflow" phenomenon. A predictor of complications and left ventricular remodelling in reperfused anterior wall myocardial infarction. Circulation 93:223-228
20. Regoeczi E, Braian MC (1969) Organ distribution of fibrin in disseminated intravascular coagulation. Br J Haematol 17:73-81
21. Gando S, Kameue T, Nanzaki S, Nakanishi Y (1996) Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 75:224-228
22. Creasey AA, Chang ACK, Feigen L, Wun TC, Taylor FB Jr, Hinshaw LB (1993) Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 91:2850-2856
23. Kessler CM, Tang Z, Jacobs HM, Szymanski LM (1997) The suprapharmacological dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminate intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity. Blood 89:4393-4401
24. Levi M, ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 19:586-592
25. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561
26. Moore KL, Esmon CT, Esmon NL (1989) Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73:159-165
27. Kobayashi M, Ozawa T, Shimada K (1990) Human recombinant interleukin 1B and tumor necrosis factor a mediated suppression of heparin like compounds on cultured porcine aortic endothelial cells. J Cell Physiol 144:383-390
28. Coliman RW, Robboy SJ, Minna JD (1979) Disseminated intravascular coagulation - a reappraisal. Annu Rev Med 30:359-374
29. Sharp AA (1977) Diagnosis and management of disseminated intravascular coagulation. Br Med Bull 33:265-272
30. Lazarchuk J, Kizer J (1987) Interaction of fibrinolytic, coagulation and kinin systems and related pathology. In: Pittiglio DH, Sacher RA (eds) Clinical hematology and fundamentals of hemostasis. Davis, Philadelphia, pp 381-391
31. Coliman RW, Robboy SJ, Minna JD (1972) Disseminated intravascular coagulation: an approach. Am J Med 52:679-689
32. Margaglione M, Di Minno G, Grandone E, Secchione G, Celentano E, Cappucci G (1994) Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb 14:1741-1745
33. Thogersen AM, Jansson JH, Boman K, Nilsson TK, Weineall L, Huhtsaari F, Hallmens G (1998) High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as a independent primary risk factor. Circulation 98:2241-2247
34. Francis RB Jr, Kawanishi D, Baruch T, Mahrer P, Rahimtoola S, Feinstein DI (1988) Impaired fibrinolysis in coronary heart disease. Am Heart J 115:776-780
35. Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C (1987) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2:3-9
36. Hamsten A, Wiman B, de Faire U, Blomback M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557-1563
37. Caputo M, Mantini G, Floriani I, Ciceri M, Noseda A, Bonomo L (1996) Tissue plasminogen activator, tissue plasminogen activator inhibitor and lipoprotein in patients with coronary, epiaortic and peripheral occlusive artery disease. Eur Heart J 17:1329-1336
38. Smith FB, Lee AJ, Hau CM, Rumley A, Lowe GD, Fowkes FG (2000) Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study. Blood Coagul Fibrinolysis 11:43-50
39. Yamami N, Shimaya K, Sera AM, Fujita H, Shibayama M, Mano Y, Maruyama M, Mihara H (1996) Alterations of fibrinolytic activity in human during and after hyperbaric oxygen exposure. Appl Human Sci 15:239-242